# EDGAR Filing Document

**Accession Number:** 0000880793
**File Stem:** 0001193125-23-023452
**Filing Date:** 2023-2
**Character Count:** 4031
**Document Hash:** 00d09bcd1073b7c60f8df061c572e65a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-023452.hdr.sgml**: 20230203

**ACCESSION NUMBER**: 0001193125-23-023452

**CONFORMED SUBMISSION TYPE**: 497

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230203

**DATE AS OF CHANGE**: 20230203

**EFFECTIVENESS DATE**: 20230203

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MERRILL LYNCH LIFE VARIABLE ANNUITY SEPARATE ACCOUNT A
- **CENTRAL INDEX KEY:** 0000880793
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** AR
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 497
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-232456
- **FILM NUMBER:** 23583848

**BUSINESS ADDRESS:**
- **STREET 1:** 6400 C STREET SW
- **CITY:** CEDAR RAPIDS
- **STATE:** IA
- **ZIP:** 52404
- **BUSINESS PHONE:** 319-355-8366

**MAIL ADDRESS:**
- **STREET 1:** 6400 C STREET SW
- **CITY:** CEDAR RAPIDS
- **STATE:** IA
- **ZIP:** 52404

## Series and Classes Contracts Data

### MERRILL LYNCH LIFE VARIABLE ANNUITY SEPARATE ACCOUNT A (Series ID: S000010583)

---

|  |  |
|:---|:---|
| Class Name                        | Class ID   |
| Investor Choice (Investor Series) | C000214612 |

---

## Series and Classes Contracts Data

### MERRILL LYNCH LIFE VARIABLE ANNUITY SEPARATE ACCOUNT A (Series ID: S000010583)

| Class ID   | Class Name                        | Ticker Symbol   |
|:---|:---|:---|
| C000214612 | Investor Choice (Investor Series) |  |

**Supplement dated April February 3, 2023** 

**To the Prospectuses Dated** 

---

| | | | |
|:---|:---|:---|:---|
| **May 1, 2015 Merrill Lynch Investor Choice Annuity (Investor Series)** | **May 1, 2015 Merrill Lynch Investor Choice Annuity (Investor Series)** | **May 1, 2015 Merrill Lynch Investor Choice Annuity (Investor Series)** | **May 1, 2015 Merrill Lynch Investor Choice Annuity (Investor Series)** |
|  | **May 1, 2007 Merrill Lynch Retirement Power** | **May 1, 2005** | **Merrill Lynch Retirement Optimizer** |

---

**Issued by** 

**TRANSAMERICA LIFE INSURANCE COMPANY** 

**MERRILL LYNCH LIFE VARIABLE ANNUITY SEPARATE ACCOUNT A** 

Effective on April 28, 2023 (the **"Liquidation Date"**), due to the liquidation of its underlying portfolio listed below (the "**Portfolio**"), the subaccount (the "**Subaccount**") will be liquidated.

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp; **SUBACCOUNT NAME**<br>| **PORTFOLIO NAME**<br>| **SUBADVISOR**<br>|
| &nbsp;&nbsp;&nbsp;BlackRock U.S. Government Bond V.I. Fund | BlackRock U.S. Government Bond V.I. Fund | BlackRock Advisors, LLC |

---

If you have contract value allocated to the Subaccount on the Liquidation Date, shares of the Portfolio held for you in the Subaccount will be exchanged for shares of the BlackRock Government Money Market V.I. Fund (the "Money Market Portfolio"), of equal value on the Liquidation Date, and held in the BlackRock Government Money Market V.I. Fund subaccount (the "Money Market Subaccount").

As of the start of business on the Liquidation Date, you will no longer be able to use automated transfer features such as Rebalancing Program or Dollar Cost Averaging with the Subaccount for the Portfolio. If you are using an automated transfer feature such as Rebalancing Program or Dollar Cost Averaging with the Subaccount for the Portfolio, you should contact us immediately to make alternate arrangements. If you do not make alternate arrangements any subsequent allocations to the Subaccount for the Portfolio will be directed to the Money Market Subaccount.

This Supplement updates certain information in the above referenced prospectus (the ''Prospectus''). Except as indicated in this Supplement, all other information included in the Prospectus remains unchanged. We will send you another copy of the current Prospectus or any supplement without charge upon request. Please contact our Administrative Office referenced in the Prospectus.

This Supplement must be accompanied or preceded by the current Prospectus.

Please read this Supplement carefully and retain it for future reference.